Leading pharmaceutical company to streamline quality processes across the enterprise<\/em><\/p>\n BARCELONA, Spain \u2014 10 May 2023<\/strong> \u2014 Veeva Systems<\/a> (NYSE: VEEV) today announced that Sanofi is implementing Veeva QMS<\/a> and Veeva QualityDocs<\/a> to modernize quality management across the company, including consumer healthcare (CHC). As the first key milestone of Sanofi\u2019s implementation, the CHC division is now live with Veeva QualityDocs and the first business processes of Veeva QMS. To streamline content management and GxP training, the CHC division also selected Veeva Training<\/a>. The rest of Sanofi will go live over the coming year.\n<\/p>\n \u201cBuilding a strong foundation of quality systems and processes is critical to our success,\u201d said Ma\u00eft\u00e9 Durrenbach, chief quality officer at Sanofi. \u201cVeeva Quality Suite delivers a highly scalable enterprise solution that supports our ambition to set up a more dynamic quality operating model which is high-performing and data-driven. This will enable the Sanofi Play to Win transformation.\u201d <\/p>\n Adopting a unified quality solution with industry best practices will advance Sanofi\u2019s broader digital transformation initiatives. With Veeva Quality Suite, Sanofi will standardize quality management across all divisions and sites on a modern cloud platform.<\/p>\n \u201cWe\u2019re excited to partner with Sanofi on their quality transformation journey,\u201d said Mike Jovanis, vice president, quality and manufacturing at Veeva.<\/p>\n As the shift to digital quality gains momentum, more than 500 life sciences companies use Veeva Quality applications to modernize quality management across R&D and manufacturing. To learn more about Veeva Quality, visit veeva.com\/eu\/Quality<\/a>.<\/p>\n Additional Information<\/strong> About Sanofi<\/strong> About Veeva Systems<\/strong> Veeva Forward-looking Statements<\/strong> \n###\n<\/p>\n \nContact:<\/strong>
\nConnect with Veeva on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>\n<\/p>\n
\nWe are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people\u2019s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. For more information, visit sanofi.com<\/a>.<\/p>\n
\nVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.<\/p>\n
\nThis release contains forward-looking statements regarding Veeva\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2023, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 9 and 10), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.<\/p>\n
\nJeremy Whittaker
\nVeeva Systems
\n+49-695-095-5486
\njeremy.whittaker@veeva.com<\/a>\n<\/p>\n